Craig M Crews Ph.D.
Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology and Professor of Chemistry and of Pharmacology; Executive Director, Yale Molecular Discovery Center

Departments & Organizations
Molecular, Cellular, and Developmental BiologyBiological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Biochemistry, Biophysics and Structural Biology: Cell Cycle and Signal Transduction; Drug Design, Discovery and Mechanism
Developmental Therapeutics
Center for RNA Science and Medicine, Yale
Postnatal Development & Regeneration
Pharmacology
Diabetes Endocrinology Research Center
Developmental Therapeutics
Biography
Craig Crews received his B.A. in Chemistry from the University of Virginia and his Ph.D. in Biochemistry from Harvard University. After postdoctoral training in the Department of Chemistry and Chemical Biology at Harvard, Dr. Crews joined the faculty of Yale University, where he is a Professor in the Departments of Molecular, Cellular, and Developmental Biology, Chemistry and Pharmacology. Since 2003, Dr. Crews has served as Executive Director of the Yale Center for Small Molecule Discovery. In addition to a Donaghue Foundation Young Investigator Award, Dr. Crews has received a Burroughs-Wellcome New Investigator Award, a CapCURE Research Award, the Friedrich Wilhem Bessel Award from the Humboldt Foundation and named an Ellison Medical Foundation Senior Scholar in Aging. In 2005, Dr. Crews was elected as a Fellow of the Royal Society of Chemistry.Education
- B.A., University of Virginia , 1986
- Ph.D., Harvard University , 1992
Selected Publication
- Sundberg TB, Darricarrere N, Griesbach H, Slusarski DC and CM Crews. (2011) Wnt Planar Cell Polarity Signaling Disruption by Aberrant Accumulation of the MetAP-2 Substrate Rab37. Chemistry & Biology, 18(10):1300-11
Latest Honor and Recognition
- Guest Professor(2010) , University of Konstanz
Articles

July/August 2011
Study finds key player in polycystic diseases of both kidney and liver
Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, is an...

July/August 2007
Brewing a new treatment for kidney disease
Swirled in a cup, tea leaves are said to offer a glimpse into the future. Now, Yale researchers have shown that one...
July/August 2006
A faster pipeline speeds new treatments from lab to patient
The flow of discoveries from the medical school’s labs to patients in need is proceeding at a blistering pace—in the...


